Genetic variants in the USF1 gene are associated with low-density lipoprotein cholesterol levels and incident type 2 diabetes mellitus in women: Results from the MONICA/KORA Augsburg case-cohort study, 1984-2002

European Journal of Endocrinology

Volumn 159, Issue 4, 2008, Pages 407-416

  Holzapfel, C ^a,b   Baumert, J ^a   Grallert, H ^a   Muller A M ^a,c   Thorand, B ^a   Khuseyinova, N ^d   Herder, C ^e   Meisinger, C ^a   Hauner, H ^b   Wichmann, H E ^a,c   Koenig, W ^d   Klopp, N ^a  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

^d UNIVERSITY HOSPITAL ULM   (Germany)

^e HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; UPSTREAM STIMULATORY FACTOR 1; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; UPSTREAM STIMULATORY FACTOR; USF1 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CAUCASIAN; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; GERMANY; HAPLOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; BLOOD; COHORT ANALYSIS; GENETIC PREDISPOSITION; GENETICS; INCIDENCE; MALE; METABOLISM; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SEX RATIO;

ADULT; AGED; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GERMANY; HAPLOTYPES; HUMANS; INCIDENCE; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SEX DISTRIBUTION; UPSTREAM STIMULATORY FACTORS; VARIATION (GENETICS);

EID: 54049156055     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-08-0356     Document Type: Article

References (46)

1. Ribeiro A, Pastier D, Kardassis D, Chambaz J & Cardot P. Cooperative binding of upstream stimulatory factor and hepatic nuclear factor 4 drives the transcription of the human apolipoprotein A-II gene. Journal of Biological Chemistry 1999 274 1216-1225.
2. Corre S & Galibert MD. USF as a key regulatory element of gene expression. Medical Science 2006 22 62-67.
3. Littlewood TD & Evan GI. Transcription factors 2: helix-loop-helix. Protein Profile 1995 2 621-702.
4. Frey UH, Hauner H, Jöckel KH, Manthey I, Brockmeyer N & Siffert W. A novel promoter polymorphism in the human gene GNAS affects binding of transcription factor upstream stimulatory factor 1, Galphas protein expression and body weight regulation. Pharmacogenetics and Genomics 2008 18 141-151.
5. Smih F, Rouet P. Lucas S, Mairal A, Sengenes C, Lafontan M, Vaulont S, Casado M & Langin D. Transcriptional regulation of adipocyte hormone-sensitive lipase by glucose. Diabetes 2002 51 293-300.
6. Wang D & Sul HS. Upstream stimulatory factor binding to the E-box at -65 is required for insulin regulation of the fatty acid synthase promoter. Journal of Biological Chemistry 1997 272 26367-26374.
7. Travers MT, Vallance AJ, Gourlay HT, Gill CA, Klein I, Bottema CB & Barber MC. Promoter I of the ovine acetyl-CoA carboxylase-alpha gene: an E-box motif at -114 in the proximal promoter binds upstream stimulatory factor (USF)-1 and USF-2 and acts as an insulin-response sequence in differentiating adipocytes. Biochemical Journal 2001 359 273-284.
8. Pastier D, Lacorte JM, Chambaz J, Cardot P & Ribeiro A. Two initiator-like elements are required for the combined activation of the human apolipoprotein C-III promoter by upstream stimulatory factor and hepatic nuclear factor-4. Journal of Biological Chemistry 2002 277 15199-15206.
9. Nowak M, Helleboid-Chapman A, Jakel H, Martin G, Duran-Sandoval D, Stacis B, Rubin EM, Pennacchio LA, Taskinen MR, Fruchart-Najib J & Fruchart JC. Insulin-mediated down-regulation of apolipoprotein A5 gene expression through the phosphatidyl-inositol 3-kinase pathway: role of upstream stimulatory factor. Molecular and Cellular Biology 2005 25 1537-1548.
10. Botma G, Verhoeven AJ & Jansen H. Hepatic lipase promoter activity is reduced by the C-480T and G-216A substitutions present in the common LIPC gene variant, and is increased by upstream stimulatory factor. Atherosclerosis 2001 154 625-632.
11. Yang XP, Freeman LA, Knapper CL, Amar MJ, Remaley A, Brewer HB Jr & Santamarina-Fojo S. The E-box motif in the proximal ABCA1 promoter mediates transcriptional repression of the ABCA1 gene, Journal of Lipid Research 2002 43 297-306.
12. Iynedjian PB. Identification of upstream stimulatory factor as transcriptional activator of the liver promotor of the glucokinase gene. Biochemical Journal 1998 333 705-712.
13. Yanai K, Saito T, Hirota K, Kobayashi H, Murakami K & Fukamizu A. Molecular variation of the human angiotensinogen core promotor element located between the TATA box and transcription initiation site affects its transcriptional activity. Journal of Biological Chemistry 1997 272 30558-30562.
14. Read ML, Clark AR & Docherty K. The helix-loop-helix transcription factor USF (upstream stimulatory factor) binds to a regulatory sequence of the human insulin gene enhancer. Biochemical Journal 1993 295 233-237.
15. Martin CC, Svitek CA, Oeser JK, Henderson E, Stein R & O'Brien RM. Upstream stimulatory factor (USF) and neurogenic differentiation/ beta-cell E box transactivator 2 (NeuroD/BETA2) contribute to islet-specific glucose-6-phosphatase catalytic-subunit-related protein (IGRP) gene expression. Biochemical Journal 2003 371 675-686.
16. Pajukanta P, Nuotio I, Terwilliger JD, Porkka KV, Ylitalo K, Pihlajamäki J, Suomalainen AJ, Syvänen AC, Lehtimäki T, Viikari JS, Laakso M, Taskinen MR, Ehnholm C & Peltonen L. Linkage of familial combined hyperlipidaemia to chromosome lq21-q23. Nature Genetics 1998 18 369-373.
17. Coon H, Myers RH, Borecki IB, Arnett DK, Hunt SC, Province MA, Djousse L & Leppert MF. Replication of linkage of familial combined hyperlipidemia to chromosome 1q with additional heterogeneous effect of apolipoprotein A-I/C-III/A-IV locus. The NHLBI Family Heart Study. Arteriosclerosis, Thrombosis, and Vascular Biology 2000 20 2275-2280.
18. Lee JC, Weissglas-Volkov D, Kyttala M, Sinsheimer JS, Jokiaho A, de Bruin TW, Lusis AJ, Brennan ML, van Greevenbrock MM, van der Kallen CJ, Hazen SL & Pajukanta P. USF1 contributes to high serum lipid levels in Dutch FCHL families and US. Whites with coronary artery disease. Arteriosclerosis, Thrombosis, and Vascular Biology 2007 27 2222-2227.
19. De Graaf J, Van der Vleuten G & Stalenhoef AF. Diagnostic criteria in relation to the pathogenesis of familial combined hyperlipidemia. Seminars in Vascular Medicine 2004 4 229-240.
20. Naukkarinen J, Gentile M, Soro-Paavonen A, Saarela J, Koistinen HA, Pajukanta P, Taskinen MR & Peltonen L. USF1 and dyslipidemias: converging evidence for a functional intronic variant. Human Molecular Genetics 2005 14 2595-2605.
21. Pajukanta P, Lilja HE, Sinsheimer JS, Cantor RM, Lusis AJ, Gentile M, Duan XJ, Soro-Paavonen A, Naukkarinen J, Saarela J, Laakso M, Ehnholm C, Taskinen MR & Peltonen L. Familial combined hyperlipidemia is associated with upstream transcription factor 1 (USF1). Nature Genetics 2004 36 371-376.
22. Huertas-Vazquez A, Aquilar-Salinas C, Lusis AJ, Cantor RM, Canizales-Quinteros S, Lee JC, Mariana-Nunez L, Riba-Ramirez RM, Jokiaho A, Tusie-Luna T & Pajukanta P. Familial combined hyperlipidemia in Mexicans: association with upstream transcription factor 1 and linkage on chromosome 16q24.1. Arteriosclerosis, Thrombosis, and Vascular Biology 2005 25 1985-1991.
23. Coon H, Xin Y, Hopkins PN, Cawthon RM, Hasstedt SJ & Hunt SC. Upstream stimulatory factor 1 associated with familial combined hyperlipidemia, LDL cholesterol, and triglycerides. Human Genetics 2005 117 444-451.
24. Zeggini E, Damcott CM, Hanson RL, Karim MA, Rayner NW, Groves CJ, Baier LJ, Hale TC, Hattersley AT, Hitman GA, Hunt SE, Knowler WC, Mitchell BD, Ng MC, O'Connell JR, Pollin TI, Vaxillaire M, Walker M, Wang X, Whittaker P, Xiang K, Jia W, Chan JC, Froguel P, Deloukas P, Shuldiner AR, Elbein SC & McCarthy MI. International Type 2 Diabetes 1q Consortium. Variation within the gene encoding the upstream stimulatory factor 1 does not influence susceptibility to type 2 diabetes in samples from populations with replicated evidence of linkage to chromosome 1q. Diabetes 2006 55 2541-2548.
25. Reiner AP, Carlson CS, Jenny NS, Durda JP, Siscovick DS, Nickerson DA & Tracy RP. USF1 gene variants, cardiovascular risk, and mortality in European Americans: analysis of two US cohort studies. Arteriosclerosis, Thrombosis, and Vascular Biology 2007 27 2736-2742.
26. Gibson F, Hercberg S & Froguel P. Common polymorphisms in the USF1 gene are not associated with type 2 diabetes in French Caucasians. Diabetes 2005 54 3040-3042.
27. Lee SK, Kim HJ, Kim BJ, Jo YS, Park KS, Baik HW, Hyun SH, Lee JC & Kim SA. Body mass index is associated with USF1 haplotype in Korean premenopausal women. Journal of Korean Medical Science 2008 23 83-88.
28. Auro K, Kristiansson K, Zethelius B, Berne C, Lannfelt L, Taskinen MR, Jauhiainen M, Perola M, Peltonen L & Syvänen AC. USF1 gene variants contribute to metabolic traits in men in a longitudinal 32-year follow-up study. Diabetologia 2008 51 464-472.
29. Putt W Palmen J, Nicaud V, Tregouet DA, Tahri-Daizadeh N, Flavell DM, Humphries SE & Talmud PJ. Variation in USF1 shows haplotype effects, gene:gene and gene:environment associations with glucose and lipid parameters in the European Atherosclerosis Research Study II. Human Molecular Genetics 2004 13 1587-1597.
30. Meisinger C, Thorand B, Schneider A, Stieber J, Döring A & Löwel H. Sex differences in risk factors for incident type 2 diabetes mellitus: the MONICA Augsburg cohort study. Archives of Internal Medicine 2002 162 82-89.
31. Thorand B, Baumert J, Kolb H, Meisinger C, Chabless L, Koenig W & Herder C. Sex differences in the prediction of type 2 diabetes by inflammatory markers: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002. Diabetes Care 2007 30 854-860.
32. Kolz M, Baumert J, Müller M, Khuseyinova N, Klopp N, Thorand B, Meisinger C, Herder C, Koenig W & Illig T. Association between variations in the TLR4 gene and incident type 2 diabetes is modified by the ratio of total cholesterol to HDL-cholesterol. BMC Medical Genetics 2008 9 9.
33. Wichmann HE, Gieger C, Illig T & for the MONICA/KORA Study Group,. KORA-gen - resource for population genetics, controls and broad spectrum of disease phenotypes. Gesundheitswesen 2005 67 26-30.
34. Holle R, Happich M, Löwel H, Wichmann HE & MONICA/KORA Study Group. KORA - a research platform for population based health research. Gesundheitswesen 2005 67 S19-S25.
35. Thorand B, Kolb H, Baumert J, Koenig W, Chambless L, Meisinger C, Illig T, Martin S & Herder C. Elevated levels of interleukin-18 predict the development of type 2 diabetes: results from the MONICA/KORA Augsburg Study, 1984-2002. Diabetes 2005 54 2932-2938.
36. Herder C. Baumert J, Thorand B, Koenig W, de Jager W, Meisinger C, Illig T, Martin S & Kolb H. Chemokines as risk factors for type 2 diabetes: results from the MONICA/KORA Augsburg Study, 1984-2002. Diabetologia 2006 49 921-929.
37. Herder C, Klopp N, Baumert J, Muller M, Khuseyinova N, Meisinger C, Martin S, Illig T, Koenig W & Thorand B. Effect of macrophage migration inhibitory factor (MIF) gene variants and MIF serum concentrations on the risk of type 2 diabetes: results from the MONICA/ KORA Augsburg case-cohort study, 1984-2002. Diabetologia 2008 51 276-284.
38. Barlow WE. Robust variance estimation for the case-cohort design. Biometrics 1994 50 1064-1072.
39. Li J & Ji L. Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix. Heredity 2005 95 221-227.
40. Cai J & Zeng D. Sample size/power calculation for case-cohort studies. Biometrics 2004 60 1015-1024.
41. Kristiansson K, Ilveskoski E, Lehtimäki T, Peltonen L, Perola M & Karhunen PJ. Association analysis of allelic variants of USF1 in coronary atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology 2008 28 983-989.
42. Komulainen K, Alanne M, Auro K, Kilpikari R, Pajukanta P, Saareta J, Ellonen P, Salminen K, Kulathinal S, Kuulasmaa K, Silander K, Salomaa V, Perola M & Peltonen L. Risk alleles of USF1 gene predict cardiovascular disease of women in two prospective studies. PLoS Genetics 2006 2 e69.
43. Ng MC, Miyake K, So WY, Poon EW, Lam VK, Li JK, Cox NJ, Bell GI & Chan JC. The linkage and association of the gene encoding upstream stimulatory factor 1 with type 2 diabetes and metabolic syndrome in the Chinese population. Diabetologia 2005 48 2018-2024.
44. Van der Vleuten GM, Isaacs A, Hijmans A, van Duijn CM, Stalenhoef AFH & de Graaf J. The involvement of upstream stimulatory factor 1 (USF1) in Dutch patients with familial combined hyperlipidemia. Journal of Lipid Research 2007 48 193-200.
45. Hoffstedt J, Rydén M, Wahrenberg H, van Harmelen V & Arner P. Upstream transcription factor-1 gene polymorphism is associated with increased adipocyte lipolysis. Journal of Clinical Endocrinology and Metabolism 2005 90 5356-5360.
46. Kantartzis K, Fritsche A, Machicao F, Stumvoll M, Machann J, Schick F, Häring HU & Stefan N. Upstream stimulatory factor 1 gene polymorphisms are associated with high antilipolytic insulin sensitivity and show gene-gene interactions. Journal of Molecular Medicine 2007 85 55-61.